Trial shows pill could reform diabeties care

GLP-1 drugs are usually injected. Representation Pic/istock

A clinical trial has revealed that orforglipron - the first oral GLP-1 class drug - may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as injectable drugs. GLP-1 class drugs are popular due to their weight-loss effects.

But they are expensive, must be refrigerated and must be injected. A pill that produces similar results is likely to be far more widely used. The drug is also being tested for weight loss in people without diabetes.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever